Global Nuclear Molecular Imaging System Market Growth 2022-2028
As the global economy mends, the 2021 growth of Nuclear Molecular Imaging System will have significant change from previous year. According to our (LP Information) latest study, the global Nuclear Molecular Imaging System market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nuclear Molecular Imaging System market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Nuclear Molecular Imaging System market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Nuclear Molecular Imaging System market, reaching US$ million by the year 2028. As for the Europe Nuclear Molecular Imaging System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Nuclear Molecular Imaging System players cover Bruker, GE Healthcare, Siemens Healthcare, and Philips Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Molecular Imaging System market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Positron Emission Tomography
Single-photon Emission Computed Tomography
Planar Scintigraphy Systems
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Neurology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Molecular Imaging System Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nuclear Molecular Imaging System by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nuclear Molecular Imaging System by Country/Region, 2017, 2022 & 2028
2.2 Nuclear Molecular Imaging System Segment by Type
2.2.1 Positron Emission Tomography
2.2.2 Single-photon Emission Computed Tomography
2.2.3 Planar Scintigraphy Systems
2.3 Nuclear Molecular Imaging System Sales by Type
2.3.1 Global Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
2.3.2 Global Nuclear Molecular Imaging System Revenue and Market Share by Type (2017-2022)
2.3.3 Global Nuclear Molecular Imaging System Sale Price by Type (2017-2022)
2.4 Nuclear Molecular Imaging System Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Neurology
2.4.4 Others
2.5 Nuclear Molecular Imaging System Sales by Application
2.5.1 Global Nuclear Molecular Imaging System Sale Market Share by Application (2017-2022)
2.5.2 Global Nuclear Molecular Imaging System Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nuclear Molecular Imaging System Sale Price by Application (2017-2022)
3 Global Nuclear Molecular Imaging System by Company
3.1 Global Nuclear Molecular Imaging System Breakdown Data by Company
3.1.1 Global Nuclear Molecular Imaging System Annual Sales by Company (2020-2022)
3.1.2 Global Nuclear Molecular Imaging System Sales Market Share by Company (2020-2022)
3.2 Global Nuclear Molecular Imaging System Annual Revenue by Company (2020-2022)
3.2.1 Global Nuclear Molecular Imaging System Revenue by Company (2020-2022)
3.2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Company (2020-2022)
3.3 Global Nuclear Molecular Imaging System Sale Price by Company
3.4 Key Manufacturers Nuclear Molecular Imaging System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Molecular Imaging System Product Location Distribution
3.4.2 Players Nuclear Molecular Imaging System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nuclear Molecular Imaging System by Geographic Region
4.1 World Historic Nuclear Molecular Imaging System Market Size by Geographic Region (2017-2022)
4.1.1 Global Nuclear Molecular Imaging System Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nuclear Molecular Imaging System Annual Revenue by Geographic Region
4.2 World Historic Nuclear Molecular Imaging System Market Size by Country/Region (2017-2022)
4.2.1 Global Nuclear Molecular Imaging System Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nuclear Molecular Imaging System Annual Revenue by Country/Region
4.3 Americas Nuclear Molecular Imaging System Sales Growth
4.4 APAC Nuclear Molecular Imaging System Sales Growth
4.5 Europe Nuclear Molecular Imaging System Sales Growth
4.6 Middle East & Africa Nuclear Molecular Imaging System Sales Growth
5 Americas
5.1 Americas Nuclear Molecular Imaging System Sales by Country
5.1.1 Americas Nuclear Molecular Imaging System Sales by Country (2017-2022)
5.1.2 Americas Nuclear Molecular Imaging System Revenue by Country (2017-2022)
5.2 Americas Nuclear Molecular Imaging System Sales by Type
5.3 Americas Nuclear Molecular Imaging System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Molecular Imaging System Sales by Region
6.1.1 APAC Nuclear Molecular Imaging System Sales by Region (2017-2022)
6.1.2 APAC Nuclear Molecular Imaging System Revenue by Region (2017-2022)
6.2 APAC Nuclear Molecular Imaging System Sales by Type
6.3 APAC Nuclear Molecular Imaging System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nuclear Molecular Imaging System by Country
7.1.1 Europe Nuclear Molecular Imaging System Sales by Country (2017-2022)
7.1.2 Europe Nuclear Molecular Imaging System Revenue by Country (2017-2022)
7.2 Europe Nuclear Molecular Imaging System Sales by Type
7.3 Europe Nuclear Molecular Imaging System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Molecular Imaging System by Country
8.1.1 Middle East & Africa Nuclear Molecular Imaging System Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nuclear Molecular Imaging System Revenue by Country (2017-2022)
8.2 Middle East & Africa Nuclear Molecular Imaging System Sales by Type
8.3 Middle East & Africa Nuclear Molecular Imaging System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Molecular Imaging System
10.3 Manufacturing Process Analysis of Nuclear Molecular Imaging System
10.4 Industry Chain Structure of Nuclear Molecular Imaging System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Molecular Imaging System Distributors
11.3 Nuclear Molecular Imaging System Customer
12 World Forecast Review for Nuclear Molecular Imaging System by Geographic Region
12.1 Global Nuclear Molecular Imaging System Market Size Forecast by Region
12.1.1 Global Nuclear Molecular Imaging System Forecast by Region (2023-2028)
12.1.2 Global Nuclear Molecular Imaging System Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Molecular Imaging System Forecast by Type
12.7 Global Nuclear Molecular Imaging System Forecast by Application
13 Key Players Analysis
13.1 Bruker
13.1.1 Bruker Company Information
13.1.2 Bruker Nuclear Molecular Imaging System Product Offered
13.1.3 Bruker Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bruker Main Business Overview
13.1.5 Bruker Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Nuclear Molecular Imaging System Product Offered
13.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Siemens Healthcare
13.3.1 Siemens Healthcare Company Information
13.3.2 Siemens Healthcare Nuclear Molecular Imaging System Product Offered
13.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Siemens Healthcare Main Business Overview
13.3.5 Siemens Healthcare Latest Developments
13.4 Philips Healthcare
13.4.1 Philips Healthcare Company Information
13.4.2 Philips Healthcare Nuclear Molecular Imaging System Product Offered
13.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Philips Healthcare Main Business Overview
13.4.5 Philips Healthcare Latest Developments
13.5 Canon Medical Systems
13.5.1 Canon Medical Systems Company Information
13.5.2 Canon Medical Systems Nuclear Molecular Imaging System Product Offered
13.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Canon Medical Systems Main Business Overview
13.5.5 Canon Medical Systems Latest Developments
13.6 Hitachi Medical
13.6.1 Hitachi Medical Company Information
13.6.2 Hitachi Medical Nuclear Molecular Imaging System Product Offered
13.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hitachi Medical Main Business Overview
13.6.5 Hitachi Medical Latest Developments
13.7 Digirad Corporation
13.7.1 Digirad Corporation Company Information
13.7.2 Digirad Corporation Nuclear Molecular Imaging System Product Offered
13.7.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Digirad Corporation Main Business Overview
13.7.5 Digirad Corporation Latest Developments
13.8 DDD-Diagnostics A/S
13.8.1 DDD-Diagnostics A/S Company Information
13.8.2 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Offered
13.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 DDD-Diagnostics A/S Main Business Overview
13.8.5 DDD-Diagnostics A/S Latest Developments
13.9 Neusoft Medical Systems Co. Ltd.
13.9.1 Neusoft Medical Systems Co. Ltd. Company Information
13.9.2 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Offered
13.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Neusoft Medical Systems Co. Ltd. Main Business Overview
13.9.5 Neusoft Medical Systems Co. Ltd. Latest Developments
13.10 Mediso Medical Imaging Systems, Ltd.
13.10.1 Mediso Medical Imaging Systems, Ltd. Company Information
13.10.2 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Offered
13.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mediso Medical Imaging Systems, Ltd. Main Business Overview
13.10.5 Mediso Medical Imaging Systems, Ltd. Latest Developments
13.11 SurgicEye GmbH
13.11.1 SurgicEye GmbH Company Information
13.11.2 SurgicEye GmbH Nuclear Molecular Imaging System Product Offered
13.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SurgicEye GmbH Main Business Overview
13.11.5 SurgicEye GmbH Latest Developments
13.12 CMR Naviscan Corporation
13.12.1 CMR Naviscan Corporation Company Information
13.12.2 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Offered
13.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CMR Naviscan Corporation Main Business Overview
13.12.5 CMR Naviscan Corporation Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Nuclear Molecular Imaging System Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nuclear Molecular Imaging System Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Positron Emission Tomography
Table 4. Major Players of Single-photon Emission Computed Tomography
Table 5. Major Players of Planar Scintigraphy Systems
Table 6. Global Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 7. Global Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
Table 8. Global Nuclear Molecular Imaging System Revenue by Type (2017-2022) & ($ million)
Table 9. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2022)
Table 10. Global Nuclear Molecular Imaging System Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 12. Global Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Table 13. Global Nuclear Molecular Imaging System Revenue by Application (2017-2022)
Table 14. Global Nuclear Molecular Imaging System Revenue Market Share by Application (2017-2022)
Table 15. Global Nuclear Molecular Imaging System Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Nuclear Molecular Imaging System Sales by Company (2020-2022) & (K Units)
Table 17. Global Nuclear Molecular Imaging System Sales Market Share by Company (2020-2022)
Table 18. Global Nuclear Molecular Imaging System Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Nuclear Molecular Imaging System Revenue Market Share by Company (2020-2022)
Table 20. Global Nuclear Molecular Imaging System Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Nuclear Molecular Imaging System Producing Area Distribution and Sales Area
Table 22. Players Nuclear Molecular Imaging System Products Offered
Table 23. Nuclear Molecular Imaging System Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nuclear Molecular Imaging System Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Nuclear Molecular Imaging System Sales Market Share Geographic Region (2017-2022)
Table 28. Global Nuclear Molecular Imaging System Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Nuclear Molecular Imaging System Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Nuclear Molecular Imaging System Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Nuclear Molecular Imaging System Sales Market Share by Country/Region (2017-2022)
Table 32. Global Nuclear Molecular Imaging System Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Nuclear Molecular Imaging System Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 35. Americas Nuclear Molecular Imaging System Sales Market Share by Country (2017-2022)
Table 36. Americas Nuclear Molecular Imaging System Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Nuclear Molecular Imaging System Revenue Market Share by Country (2017-2022)
Table 38. Americas Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 39. Americas Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
Table 40. Americas Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 41. Americas Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Table 42. APAC Nuclear Molecular Imaging System Sales by Region (2017-2022) & (K Units)
Table 43. APAC Nuclear Molecular Imaging System Sales Market Share by Region (2017-2022)
Table 44. APAC Nuclear Molecular Imaging System Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Nuclear Molecular Imaging System Revenue Market Share by Region (2017-2022)
Table 46. APAC Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 47. APAC Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
Table 48. APAC Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 49. APAC Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Table 50. Europe Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 51. Europe Nuclear Molecular Imaging System Sales Market Share by Country (2017-2022)
Table 52. Europe Nuclear Molecular Imaging System Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Nuclear Molecular Imaging System Revenue Market Share by Country (2017-2022)
Table 54. Europe Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 55. Europe Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
Table 56. Europe Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 57. Europe Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Nuclear Molecular Imaging System Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Nuclear Molecular Imaging System Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Nuclear Molecular Imaging System Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Nuclear Molecular Imaging System Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Nuclear Molecular Imaging System Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Nuclear Molecular Imaging System Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Nuclear Molecular Imaging System Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Nuclear Molecular Imaging System
Table 67. Key Market Challenges & Risks of Nuclear Molecular Imaging System
Table 68. Key Industry Trends of Nuclear Molecular Imaging System
Table 69. Nuclear Molecular Imaging System Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Nuclear Molecular Imaging System Distributors List
Table 72. Nuclear Molecular Imaging System Customer List
Table 73. Global Nuclear Molecular Imaging System Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Nuclear Molecular Imaging System Sales Market Forecast by Region
Table 75. Global Nuclear Molecular Imaging System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Nuclear Molecular Imaging System Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Nuclear Molecular Imaging System Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Nuclear Molecular Imaging System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Nuclear Molecular Imaging System Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Nuclear Molecular Imaging System Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Nuclear Molecular Imaging System Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Nuclear Molecular Imaging System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Nuclear Molecular Imaging System Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Nuclear Molecular Imaging System Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Nuclear Molecular Imaging System Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Nuclear Molecular Imaging System Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Nuclear Molecular Imaging System Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Nuclear Molecular Imaging System Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Nuclear Molecular Imaging System Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Nuclear Molecular Imaging System Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Nuclear Molecular Imaging System Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Nuclear Molecular Imaging System Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bruker Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 94. Bruker Nuclear Molecular Imaging System Product Offered
Table 95. Bruker Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Bruker Main Business
Table 97. Bruker Latest Developments
Table 98. GE Healthcare Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 99. GE Healthcare Nuclear Molecular Imaging System Product Offered
Table 100. GE Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. GE Healthcare Main Business
Table 102. GE Healthcare Latest Developments
Table 103. Siemens Healthcare Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 104. Siemens Healthcare Nuclear Molecular Imaging System Product Offered
Table 105. Siemens Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Siemens Healthcare Main Business
Table 107. Siemens Healthcare Latest Developments
Table 108. Philips Healthcare Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 109. Philips Healthcare Nuclear Molecular Imaging System Product Offered
Table 110. Philips Healthcare Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Philips Healthcare Main Business
Table 112. Philips Healthcare Latest Developments
Table 113. Canon Medical Systems Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 114. Canon Medical Systems Nuclear Molecular Imaging System Product Offered
Table 115. Canon Medical Systems Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Canon Medical Systems Main Business
Table 117. Canon Medical Systems Latest Developments
Table 118. Hitachi Medical Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 119. Hitachi Medical Nuclear Molecular Imaging System Product Offered
Table 120. Hitachi Medical Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Hitachi Medical Main Business
Table 122. Hitachi Medical Latest Developments
Table 123. Digirad Corporation Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 124. Digirad Corporation Nuclear Molecular Imaging System Product Offered
Table 125. Digirad Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Digirad Corporation Main Business
Table 127. Digirad Corporation Latest Developments
Table 128. DDD-Diagnostics A/S Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 129. DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Offered
Table 130. DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. DDD-Diagnostics A/S Main Business
Table 132. DDD-Diagnostics A/S Latest Developments
Table 133. Neusoft Medical Systems Co. Ltd. Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 134. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Offered
Table 135. Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Neusoft Medical Systems Co. Ltd. Main Business
Table 137. Neusoft Medical Systems Co. Ltd. Latest Developments
Table 138. Mediso Medical Imaging Systems, Ltd. Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 139. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Offered
Table 140. Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Mediso Medical Imaging Systems, Ltd. Main Business
Table 142. Mediso Medical Imaging Systems, Ltd. Latest Developments
Table 143. SurgicEye GmbH Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 144. SurgicEye GmbH Nuclear Molecular Imaging System Product Offered
Table 145. SurgicEye GmbH Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. SurgicEye GmbH Main Business
Table 147. SurgicEye GmbH Latest Developments
Table 148. CMR Naviscan Corporation Basic Information, Nuclear Molecular Imaging System Manufacturing Base, Sales Area and Its Competitors
Table 149. CMR Naviscan Corporation Nuclear Molecular Imaging System Product Offered
Table 150. CMR Naviscan Corporation Nuclear Molecular Imaging System Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. CMR Naviscan Corporation Main Business
Table 152. CMR Naviscan Corporation Latest Developments
List of Figures
Figure 1. Picture of Nuclear Molecular Imaging System
Figure 2. Nuclear Molecular Imaging System Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Molecular Imaging System Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nuclear Molecular Imaging System Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nuclear Molecular Imaging System Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Positron Emission Tomography
Figure 10. Product Picture of Single-photon Emission Computed Tomography
Figure 11. Product Picture of Planar Scintigraphy Systems
Figure 12. Global Nuclear Molecular Imaging System Sales Market Share by Type in 2021
Figure 13. Global Nuclear Molecular Imaging System Revenue Market Share by Type (2017-2022)
Figure 14. Nuclear Molecular Imaging System Consumed in Oncology
Figure 15. Global Nuclear Molecular Imaging System Market: Oncology (2017-2022) & (K Units)
Figure 16. Nuclear Molecular Imaging System Consumed in Cardiology
Figure 17. Global Nuclear Molecular Imaging System Market: Cardiology (2017-2022) & (K Units)
Figure 18. Nuclear Molecular Imaging System Consumed in Neurology
Figure 19. Global Nuclear Molecular Imaging System Market: Neurology (2017-2022) & (K Units)
Figure 20. Nuclear Molecular Imaging System Consumed in Others
Figure 21. Global Nuclear Molecular Imaging System Market: Others (2017-2022) & (K Units)
Figure 22. Global Nuclear Molecular Imaging System Sales Market Share by Application (2017-2022)
Figure 23. Global Nuclear Molecular Imaging System Revenue Market Share by Application in 2021
Figure 24. Nuclear Molecular Imaging System Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Nuclear Molecular Imaging System Revenue Market Share by Company in 2021
Figure 26. Global Nuclear Molecular Imaging System Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Nuclear Molecular Imaging System Revenue Market Share by Geographic Region in 2021
Figure 28. Global Nuclear Molecular Imaging System Sales Market Share by Region (2017-2022)
Figure 29. Global Nuclear Molecular Imaging System Revenue Market Share by Country/Region in 2021
Figure 30. Americas Nuclear Molecular Imaging System Sales 2017-2022 (K Units)
Figure 31. Americas Nuclear Molecular Imaging System Revenue 2017-2022 ($ Millions)
Figure 32. APAC Nuclear Molecular Imaging System Sales 2017-2022 (K Units)
Figure 33. APAC Nuclear Molecular Imaging System Revenue 2017-2022 ($ Millions)
Figure 34. Europe Nuclear Molecular Imaging System Sales 2017-2022 (K Units)
Figure 35. Europe Nuclear Molecular Imaging System Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Nuclear Molecular Imaging System Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Nuclear Molecular Imaging System Revenue 2017-2022 ($ Millions)
Figure 38. Americas Nuclear Molecular Imaging System Sales Market Share by Country in 2021
Figure 39. Americas Nuclear Molecular Imaging System Revenue Market Share by Country in 2021
Figure 40. United States Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Nuclear Molecular Imaging System Sales Market Share by Region in 2021
Figure 45. APAC Nuclear Molecular Imaging System Revenue Market Share by Regions in 2021
Figure 46. China Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Nuclear Molecular Imaging System Sales Market Share by Country in 2021
Figure 53. Europe Nuclear Molecular Imaging System Revenue Market Share by Country in 2021
Figure 54. Germany Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Nuclear Molecular Imaging System Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Nuclear Molecular Imaging System Revenue Market Share by Country in 2021
Figure 61. Egypt Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Nuclear Molecular Imaging System Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Nuclear Molecular Imaging System in 2021
Figure 67. Manufacturing Process Analysis of Nuclear Molecular Imaging System
Figure 68. Industry Chain Structure of Nuclear Molecular Imaging System
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets